Prestige Consumer Healthcare PBH Business Segments
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| International OTC Healthcare | $175.13M-0.3% | $175.63M-2.0% | $179.26M-0.3% | $179.88M+1.2% | $177.75M+1.0% | |
| North American OTC Healthcare | $913.58M-1.6% | $927.98M-0.3% | $931.22M-1.0% | $940.27M-2.1% | $960.01M+1.9% | |
| Gross Profit by Business | ||||||
| International OTC Healthcare | $94.7M-3.7% | $98.3M-3.4% | $101.81M-2.1% | $103.99M+0.6% | $103.32M+2.1% | |
| North American OTC Healthcare | $500.88M-3.9% | $520.99M0.0% | $521.16M-0.7% | $524.78M-1.2% | $531.14M+3.1% | |
| Contribution Margin by Business | ||||||
| International OTC Healthcare | $66.77M-6.1% | $71.07M-5.2% | $75M-3.0% | $77.33M+0.4% | $77.03M+2.2% | |
| North American OTC Healthcare | $380.03M-4.4% | $397.52M-0.5% | $399.39M-0.2% | $400.15M-0.4% | $401.71M+4.4% | |
| Goodwill, Gross by Business | ||||||
| International OTC Healthcare | $125M+1.3% | $123.36M+1.1% | $121.97M-0.7% | $122.79M-0.1% | $122.92M-0.2% | |
| North American OTC Healthcare | $2.95B+1.8% | $2.9B+1.8% | $2.85B0.0% | $2.85B0.0% | $2.85B0.0% | |
| Cost of Sales by Business | ||||||
| International OTC Healthcare | $80.43M+4.0% | $77.33M-0.2% | $77.45M+2.1% | $75.89M+2.0% | $74.43M-0.5% | |
| North American OTC Healthcare | $412.7M+1.4% | $406.99M-0.7% | $410.06M-1.3% | $415.49M-3.1% | $428.87M+0.4% | |
| Goodwill, Impaired, Accumulated Impairment Loss by Business | ||||||
| International OTC Healthcare | $6.35M0.0% | $6.35M0.0% | $6.35M0.0% | $6.35M0.0% | $6.35M0.0% | |
| North American OTC Healthcare | $850.06M0.0% | $850.06M0.0% | $850.06M0.0% | $850.06M0.0% | $850.06M0.0% | |
| Advertising and marketing by Business | ||||||
| International OTC Healthcare | $27.94M+2.6% | $27.23M+1.6% | $26.81M+0.6% | $26.66M+1.4% | $26.29M+1.9% | |
| North American OTC Healthcare | $120.85M-2.1% | $123.47M+1.4% | $121.78M-2.3% | $124.63M-3.7% | $129.43M-0.8% | |
| Effects of foreign currency exchange rates by Business | ||||||
| International OTC Healthcare | $1.63M— | —— | —— | —— | —— | |
| North American OTC Healthcare | -$721K— | $0— | $0— | $0— | $0— | |
| Goodwill by Business | ||||||
| International OTC Healthcare | $118.65M+1.4% | $117.02M+1.2% | $115.63M-0.7% | $116.44M-0.1% | $116.57M-0.3% | |
| North American OTC Healthcare | $2.1B+2.5% | $2.05B+2.6% | $2B0.0% | $2B0.0% | $2B0.0% | |
| Total revenues by Product | ||||||
| Analgesics | $113.94M-1.7% | $115.9M-2.5% | $118.85M+0.4% | $118.34M+0.5% | $117.7M+2.1% | |
| Cough & Cold | $101.91M-0.6% | $102.53M0.0% | $102.53M-1.9% | $104.52M-1.6% | $106.21M+0.7% | |
| Dermatologicals | $125.93M+1.1% | $124.53M-0.8% | $125.54M-0.1% | $125.7M-2.5% | $128.95M-1.3% | |
| Eye & Ear Care | $142.94M-5.8% | $151.81M-4.5% | $158.89M-5.1% | $167.5M-8.6% | $183.32M+1.5% | |
| Gastrointestinal | $259.79M-0.2% | $260.32M+0.2% | $259.85M+1.6% | $255.71M-0.1% | $255.94M+3.7% | |
| Oral Care | $101.05M+0.9% | $100.15M+3.6% | $96.64M+0.7% | $95.96M+1.0% | $95.03M+1.9% | |
| Other OTC | $15.39M+10.9% | $13.88M+4.3% | $13.31M-0.7% | $13.41M-2.7% | $13.78M+6.0% | |
| Women's Health | $227.77M-2.9% | $234.5M-0.2% | $234.86M-1.7% | $239.01M+0.9% | $236.83M+1.5% | |
| Concentration risk, percentage by Product | ||||||
| Manufacturers | 60%+0.5pp | 59.5%+0.5pp | 59%+0.5pp | 58.5%+0.5pp | 58%-3.5pp | |
| Manufacturers, United States, Canada and Australia | 21%— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Prestige Consumer Healthcare break its business down?
- Prestige Consumer Healthcare (PBH) reports total revenues by business across 2 parts — International OTC Healthcare and North American OTC Healthcare. Each is extracted from the segment footnotes and tracked over time.
- Where does Prestige Consumer Healthcare's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Prestige Consumer Healthcare's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
